Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah. Show more

675 ARAPEEN DRIVE, SALT LAKE CITY, UT, UNITED STATES, 84108, Salt Lake City, UT, 84108, USA

https://www.lipocine.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

17.4M

52 Wk Range

$1.81 - $12.37

Previous Close

$2.12

Open

$2.24

Volume

91,266

Day Range

$2.03 - $2.24

Enterprise Value

-7.251M

Cash

5.016M

Avg Qtr Burn

-2.257M

Insider Ownership

4.51%

Institutional Own.

37.86%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TLANDO (Testosterone Prodrug) Details Hypogonadism	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 1144 Details Non-alcoholic steatohepatitis	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 1107 Details Preterm birth	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Brexanolone (LPCN 1154) Details Postpartum depression	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 1148 Details Cirrhosis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 2401 Details Obesity	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 2101 (GABA Modulator) Details Epilepsy	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LPCN 2203 Details Essential tremor	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.